{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?page=3&sponsor=Allergy+Therapeutics", "query": { "sponsor": "Allergy Therapeutics", "page": 3 }, "page_size": 10 }, "pagination": { "page": 3, "page_size": 10, "total_count": 97, "total_pages": 10, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?page=4&sponsor=Allergy+Therapeutics&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?page=2&sponsor=Allergy+Therapeutics&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-09T10:37:32.385Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT00537394", "title": "Optimizing Treatment for Treatment-Experienced, HIV-Infected People", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "HIV Infections" ], "interventions": [ { "name": "Enfuvirtide", "type": "DRUG" }, { "name": "Raltegravir", "type": "DRUG" }, { "name": "Darunavir", "type": "DRUG" }, { "name": "Tipranavir", "type": "DRUG" }, { "name": "Etravirine", "type": "DRUG" }, { "name": "Maraviroc", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "National Institute of Allergy and Infectious Diseases (NIAID)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "16 Years", "maximum_age": null, "sex": "ALL", "summary": "16 Years and older" }, "enrollment_count": 517, "start_date": "2008-01", "completion_date": "2013-04", "has_results": true, "last_update_posted_date": "2021-11-04", "last_synced_at": "2026-10-09T10:37:32.385Z", "location_count": 61, "location_summary": "Birmingham, Alabama • Long Beach, California • Los Angeles, California + 34 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Long Beach", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Los Angeles", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00537394" }, { "nct_id": "NCT01403051", "title": "High Dose Vitamin D and Calcium for Bone Health in Individuals Initiating HAART", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "HIV-1 Infection" ], "interventions": [ { "name": "EFV/FTC/TDF", "type": "DRUG" }, { "name": "Calcium Carbonate", "type": "DRUG" }, { "name": "Vitamin D3", "type": "DRUG" }, { "name": "Placebo for calcium carbonate", "type": "DRUG" }, { "name": "Placebo for vitamin D3", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections", "sponsor_class": "NETWORK", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 167, "start_date": "2011-09", "completion_date": "2013-02", "has_results": true, "last_update_posted_date": "2018-10-12", "last_synced_at": "2026-10-09T10:37:32.385Z", "location_count": 38, "location_summary": "Birmingham, Alabama • Los Angeles, California • Palo Alto, California + 27 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Los Angeles", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Palo Alto", "state": "California" }, { "city": "San Diego", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01403051" }, { "nct_id": "NCT02840474", "title": "Phase 1, Open-label, Single Dose Study to Examine Safety, Tolerability, Pharmacokinetics and Virologic Impact of VRC01LS or VRC07-523LS in HIV-infected Viremic Adults", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "HIV-1" ], "interventions": [ { "name": "VRC-HIVMAB080-00-AB", "type": "BIOLOGICAL" }, { "name": "VRC-HIVMAB075-00-AB", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "National Institute of Allergy and Infectious Diseases (NIAID)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "18 Years to 70 Years" }, "enrollment_count": 16, "start_date": "2017-04-24", "completion_date": "2020-01-15", "has_results": true, "last_update_posted_date": "2025-01-30", "last_synced_at": "2026-10-09T10:37:32.385Z", "location_count": 6, "location_summary": "Birmingham, Alabama • Los Angeles, California • St Louis, Missouri + 3 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Los Angeles", "state": "California" }, { "city": "St Louis", "state": "Missouri" }, { "city": "Cincinnati", "state": "Ohio" }, { "city": "Columbus", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT02840474" }, { "nct_id": "NCT01515813", "title": "Effect of HAART Vs. Statin Treatment on Endothelial Function and Inflammation/Coagulation", "overall_status": "WITHDRAWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "HIV-1 Infection" ], "interventions": [ { "name": "Pravastatin sodium", "type": "DRUG" }, { "name": "Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections", "sponsor_class": "NETWORK", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 0, "start_date": "2011-11", "completion_date": "2014-12", "has_results": false, "last_update_posted_date": "2016-02-01", "last_synced_at": "2026-10-09T10:37:32.385Z", "location_count": 9, "location_summary": "Los Angeles, California • Torrance, California • St Louis, Missouri + 6 more", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "Torrance", "state": "California" }, { "city": "St Louis", "state": "Missouri" }, { "city": "Chapel Hill", "state": "North Carolina" }, { "city": "Durham", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT01515813" }, { "nct_id": "NCT00031408", "title": "Consent for Use of Stored Patient Specimens for Future Testing", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "HIV Infections" ], "interventions": [], "intervention_types": [], "sponsor": "Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections", "sponsor_class": "NETWORK", "healthy_volunteers": true, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "ALL", "summary": "Not listed" }, "enrollment_count": 17444, "start_date": "2002-02-13", "completion_date": "2027-12-31", "has_results": false, "last_update_posted_date": "2025-10-07", "last_synced_at": "2026-10-09T10:37:32.385Z", "location_count": 62, "location_summary": "Los Angeles, California • San Diego, California • San Francisco, California + 32 more", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "San Francisco", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00031408" }, { "nct_id": "NCT00442962", "title": "HIV Treatment Reinitiation in Women Who Received Anti-HIV Drugs to Prevent Mother-to-Child Transmission of HIV", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "HIV Infections" ], "interventions": [ { "name": "Efavirenz", "type": "DRUG" }, { "name": "Emtricitabine/Tenofovir disoproxil fumarate", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections", "sponsor_class": "NETWORK", "healthy_volunteers": false, "eligibility": { "minimum_age": "16 Years", "maximum_age": null, "sex": "FEMALE", "summary": "16 Years and older · Female only" }, "enrollment_count": 54, "start_date": "2007-05", "completion_date": "2010-12", "has_results": true, "last_update_posted_date": "2018-10-12", "last_synced_at": "2026-10-09T10:37:32.385Z", "location_count": 6, "location_summary": "San Diego, California • Boston, Massachusetts • St Louis, Missouri + 3 more", "locations": [ { "city": "San Diego", "state": "California" }, { "city": "Boston", "state": "Massachusetts" }, { "city": "St Louis", "state": "Missouri" }, { "city": "New York", "state": "New York" }, { "city": "The Bronx", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT00442962" }, { "nct_id": "NCT06698549", "title": "A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of ALG-097558 in Subjects With Renal Impairment and in Healthy Subjects With Normal Renal Function", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "COVID 19" ], "interventions": [ { "name": "ALG-097558", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Aligos Therapeutics", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 12, "start_date": "2025-02-20", "completion_date": "2025-08-13", "has_results": true, "last_update_posted_date": "2026-08-25", "last_synced_at": "2026-10-09T10:37:32.385Z", "location_count": 3, "location_summary": "Miami, Florida • Orlando, Florida • Tampa, Florida", "locations": [ { "city": "Miami", "state": "Florida" }, { "city": "Orlando", "state": "Florida" }, { "city": "Tampa", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT06698549" }, { "nct_id": "NCT06568861", "title": "A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of ALG-097558 in Subjects With Hepatic Impairment and in Healthy Subjects With Normal Hepatic Function", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "COVID-19" ], "interventions": [ { "name": "ALG-097558", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Aligos Therapeutics", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 16, "start_date": "2025-01-13", "completion_date": "2025-07-28", "has_results": true, "last_update_posted_date": "2026-08-05", "last_synced_at": "2026-10-09T10:37:32.385Z", "location_count": 2, "location_summary": "Miami, Florida • Orlando, Florida", "locations": [ { "city": "Miami", "state": "Florida" }, { "city": "Orlando", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT06568861" }, { "nct_id": "NCT04042740", "title": "Glecaprevir/Pibrentasvir Fixed-dose Combination Treatment for Acute Hepatitis C Virus Infection", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Hepatitis C Infection", "HIV Infection" ], "interventions": [ { "name": "Glecaprevir/Pibrentasvir (G/P)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections", "sponsor_class": "NETWORK", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 45, "start_date": "2019-11-20", "completion_date": "2023-08-22", "has_results": true, "last_update_posted_date": "2024-07-11", "last_synced_at": "2026-10-09T10:37:32.385Z", "location_count": 11, "location_summary": "San Diego, California • San Francisco, California • Aurora, Colorado + 6 more", "locations": [ { "city": "San Diego", "state": "California" }, { "city": "San Francisco", "state": "California" }, { "city": "Aurora", "state": "Colorado" }, { "city": "Washington D.C.", "state": "District of Columbia" }, { "city": "Baltimore", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT04042740" }, { "nct_id": "NCT00086372", "title": "Long-term Follow-up of HIV Infected Patients Identified During Early Infection", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "HIV Infections" ], "interventions": [], "intervention_types": [], "sponsor": "National Institute of Allergy and Infectious Diseases (NIAID)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "13 Years", "maximum_age": null, "sex": "ALL", "summary": "13 Years and older" }, "enrollment_count": 157, "start_date": "2003-07", "completion_date": "2007-04", "has_results": false, "last_update_posted_date": "2012-10-29", "last_synced_at": "2026-10-09T10:37:32.385Z", "location_count": 22, "location_summary": "Birmingham, Alabama • Los Angeles, California • San Diego, California + 14 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Los Angeles", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "San Francisco", "state": "California" }, { "city": "Torrance", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00086372" } ] }